Top 4 Stocks In The Biotechnology Industry With The Highest Revenue

Below are the biotechnology stocks on the NYSE and the NASDAQ in terms of revenue. The trailing-twelve-month revenue at Amgen AMGN is $19.46 billion. Amgen's profit margin for the same period is 25.74%. The trailing-twelve-month revenue at Gilead Sciences GILD is $17.44 billion. Gilead Sciences' ROE for the same period is 53.55%. The trailing-twelve-month revenue at Biogen Idec BIIB is $8.34 billion. Biogen Idec's EPS for the same period is $8.04. The trailing-twelve-month revenue at Celgene CELG is $7.03 billion. Celgene's PEG ratio is 0.89.